What is NDC 14445-183?

14445-183 is the product NDC for Rivaroxaban, Rivaroxaban 15 mg/1 tablet, film coated, listed with the FDA by Indoco Remedies Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Indoco Remedies Limited, NDC labeler code 14445. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rivaroxaban?

32 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rivaroxaban NDC 14445-183 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)14445-183Labeler and product segments. Claims need a package NDC.

Product NDC at billing width14445-0183Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
14445-183-10	1444501831014445018310	10 BLISTER PACK in 1 CARTON (14445-183-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK (14445-183-02)Marketed from Aug 11, 2025
14445-183-30	1444501833014445018330	30 TABLET, FILM COATED in 1 BOTTLE (14445-183-30)Marketed from Aug 11, 2025
14445-183-90	1444501839014445018390	90 TABLET, FILM COATED in 1 BOTTLE (14445-183-90)Marketed from Aug 11, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivaroxaban
Generic name (nonproprietary): rivaroxaban
Active ingredients: Rivaroxaban — 15 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Indoco Remedies LimitedNDC labeler code 14445
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218445
Marketing start: Aug 11, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Factor Xa Inhibitors (Mechanism)
Identifiers: Product ID 14445-183_b57414a3-eca8-4cda-b7eb-7c060d52a6b6SPL ID b57414a3-eca8-4cda-b7eb-7c060d52a6b6SPL set ID 9fee7136-c8fd-4bea-ab15-7a0e7292396dRxCUI 1114198, 1232082, 1232086, 2059015UNII 9NDF7JZ4M3UPC 0314445184301, 0314445147603, 0314445148303, 0314445183304
Pharmacologic class: Factor Xa Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N414445018310 followed by a unit qualifier and the quantity

Package 14445-0183-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 28, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Rivaroxaban tablet is a factor Xa inhibitor indicated: to reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation ( 1.1 ) for treatment of deep vein thrombosis (DVT) ( 1.2 ) for treatment of pulmonary embolism (PE) ( 1.3 ) for reduction in the risk of recurrence of DVT or PE ( 1.4 ) for the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery ( 1.5 ) for prophylaxis of venous thromboembolism (VTE) in acutely ill medical patients ( 1.6 ) to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD) ( 1.7 ) to reduce the risk of major thrombotic vascular events in patients with peripheral arter…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 14445-183

What is NDC 14445-183?: 14445-183 is the product NDC for Rivaroxaban, Rivaroxaban 15 mg/1 tablet, film coated, listed with the FDA by Indoco Remedies Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rivaroxaban.
What is the active ingredient?: Rivaroxaban.
Who is the labeler?: Indoco Remedies Limited, NDC labeler code 14445. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rivaroxaban?: 32 other product NDCs are listed under this name. See all Rivaroxaban NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rivaroxaban NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Lifestar Pharma LLC	70756-006	70756-0006-1270756-0006-6070756-0006-81+1 more
Rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Micro Labs Limited	42571-345	42571-0345-0542571-0345-3042571-0345-60
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-890	72603-0890-0172603-0890-02
rivaroxaban	Rivaroxaban 10 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0540	55488-0540-01
rivaroxaban	Rivaroxaban 15 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0541	55488-0541-01
rivaroxaban	Rivaroxaban 20 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0542	55488-0542-01
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	XLCare Pharmaceuticals, Inc.	72865-321	72865-0321-1872865-0321-60
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-416	72205-0416-0272205-0416-0372205-0416-04+1 more
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, CoatedOral	Sun Pharmaceutical Industries, Inc.	51672-4228	51672-4228-0451672-4228-09
rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-405	71921-0405-0671921-0405-21

All 33 Rivaroxaban NDCs

Other NDCs under ANDA 218445

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218445
Product	Strength	Form · route	Labeler	Product NDC
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	Indoco Remedies Limited	14445-147
Rivaroxaban	Rivaroxaban 10 mg/1	Tablet, Film coatedOral	Indoco Remedies Limited	14445-148
Rivaroxaban	Rivaroxaban 20 mg/1	Tablet, Film coatedOral	Indoco Remedies Limited	14445-184
rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-405